Valve Thrombosis After Transcatheter Mitral Valve Replacement

Transcatheter mitral valve replacement (TMVR) is a therapeutic option for patients with contraindication or high risk for surgical treatment and failed surgical bioprosthesis or annuloplasty, or even calcific mitral valve disease (1,2). Two of the 3 patients discussed here were asymptomatic at diagn...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2016-10, Vol.68 (16), p.1814-1815
Hauptverfasser: Capretti, Giuliana, MD, Urena, Marina, MD, PhD, Himbert, Dominique, MD, Brochet, Eric, MD, Goublaire, Coppelia, MD, Verdonk, Constance, MD, Carrasco, Jose Luis, MD, Ghodbane, Walid, MD, Messika-Zeitoun, David, MD, PhD, Iung, Bernard, MD, PhD, Nataf, Patrick, MD, Vahanian, Alec, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Transcatheter mitral valve replacement (TMVR) is a therapeutic option for patients with contraindication or high risk for surgical treatment and failed surgical bioprosthesis or annuloplasty, or even calcific mitral valve disease (1,2). Two of the 3 patients discussed here were asymptomatic at diagnosis, and therefore, this complication may remain undiagnosed unless echocardiographic follow-up is systematically performed. [...]only a mild increase of transmitral gradient was observed in 2 cases. [...]thrombosis of a THV may be overlooked if only TTE is performed.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2016.07.757